Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults
Clinical trial NCT05258669 · UNKNOWN
Trial details
- NCT number
- NCT05258669
- Sponsor
- Ocugen
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-20
- Primary completion
- 2023-09-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.